Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- levamisole
- Palcohol (ethanol (alcohol))
Interactions between your drugs
levamisole ethanol (alcohol)
Applies to: levamisole, Palcohol (ethanol (alcohol))
GENERALLY AVOID: Case histories have suggested that levamisole is associated with some side effects (including headache, fever, shivers, and dizziness) that suggest an disulfiram-like interaction with alcohol. These side effects could be alleviated by total abstinence from alcohol. No mechanism has been established for this interaction.
MANAGEMENT: Patients receiving levamisole should avoid alcohol.
References (3)
- (2001) "Product Information. Ergamisol (levamisole)." Janssen Pharmaceuticals
- Renoux G (1980) "The general immunopharmacology of levamisole." Drugs, 19, p. 89-99
- Renoux G (1978) "Modulation of immunity by levamisole." Pharmacol Ther [B], 2, p. 397-422
Drug and food/lifestyle interactions
levamisole food/lifestyle
Applies to: levamisole
GENERALLY AVOID: Case histories have suggested that levamisole is associated with some side effects (including headache, fever, shivers, and dizziness) that suggest an disulfiram-like interaction with alcohol. These side effects could be alleviated by total abstinence from alcohol. No mechanism has been established for this interaction.
MANAGEMENT: Patients receiving levamisole should avoid alcohol.
References (3)
- (2001) "Product Information. Ergamisol (levamisole)." Janssen Pharmaceuticals
- Renoux G (1980) "The general immunopharmacology of levamisole." Drugs, 19, p. 89-99
- Renoux G (1978) "Modulation of immunity by levamisole." Pharmacol Ther [B], 2, p. 397-422
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Topotecan
Topotecan is used for cancer, cervical cancer, ovarian cancer, small cell lung cancer
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Fludarabine
Fludarabine is used for cancer, chronic lymphocytic leukemia, chronic myelogenous leukemia ...
Vinblastine
Vinblastine is used for breast cancer, cancer, choriocarcinoma, histiocytosis, hodgkin's lymphoma ...
Chlorambucil
Chlorambucil (Leukeran) is an anti-cancer chemotherapy drug used for treatment of Hodgkin’s disease ...
Ifosfamide
Ifosfamide is used for cancer, cervical cancer, testicular cancer
Etoposide
Etoposide is used for cancer, hodgkin's lymphoma, multiple myeloma, ovarian cancer, small cell lung ...
Vincristine
Vincristine is used for acute lymphocytic leukemia, acute myeloid leukemia, anaplastic ...
Doxorubicin
Doxorubicin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.